TK Inhibitor Pazopanib Primes DCs by Downregulation of the β-Catenin Pathway. [electronic resource]
Producer: 20190425Description: 711-722 p. digitalISSN:- 2326-6074
- B7-H1 Antigen -- genetics
- Biomarkers
- Carcinoma, Renal Cell -- drug therapy
- Cell Line, Tumor
- Cytokines -- metabolism
- Dendritic Cells -- drug effects
- Extracellular Signal-Regulated MAP Kinases -- metabolism
- Gene Expression Regulation -- drug effects
- Humans
- Immunophenotyping
- Indazoles
- Kidney Neoplasms -- drug therapy
- Phagocytosis -- immunology
- Protein Kinase Inhibitors -- pharmacology
- Pyrimidines -- pharmacology
- Signal Transduction -- drug effects
- Sulfonamides -- pharmacology
- T-Lymphocytes -- drug effects
- beta Catenin -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.